167 related articles for article (PubMed ID: 31696204)
21. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma.
Koirala P; Roth ME; Gill J; Piperdi S; Chinai JM; Geller DS; Hoang BH; Park A; Fremed MA; Zang X; Gorlick R
Sci Rep; 2016 Jul; 6():30093. PubMed ID: 27456063
[TBL] [Abstract][Full Text] [Related]
22. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
[TBL] [Abstract][Full Text] [Related]
23. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical distinction of metastases of renal cell carcinoma with molecular analysis of overexpression of the chemokines CXCR2 and CXCR3 as independent positive prognostic factors for the tumorigenesis.
Rezakhaniha B; Dormanesh B; Pirasteh H; Yahaghi E; Masoumi B; Ziari K; Rahmani O
IUBMB Life; 2016 Aug; 68(8):629-33. PubMed ID: 27273823
[TBL] [Abstract][Full Text] [Related]
25. TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.
Sun KH; Sun GH; Wu YC; Ko BJ; Hsu HT; Wu ST
J Cell Mol Med; 2016 Nov; 20(11):2020-2028. PubMed ID: 27297979
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization and expression analysis of the large yellow croaker (Larimichthys crocea) chemokine receptors CXCR2, CXCR3, and CXCR4 after bacterial and poly I:C challenge.
Liu X; Kang L; Liu W; Lou B; Wu C; Jiang L
Fish Shellfish Immunol; 2017 Nov; 70():228-239. PubMed ID: 28870858
[TBL] [Abstract][Full Text] [Related]
28. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
[TBL] [Abstract][Full Text] [Related]
29. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
[TBL] [Abstract][Full Text] [Related]
30. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
31. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.
Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R
Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634
[TBL] [Abstract][Full Text] [Related]
32. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
33. Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines.
Cockwell P; Calderwood JW; Brooks CJ; Chakravorty SJ; Savage CO
Nephrol Dial Transplant; 2002 May; 17(5):734-44. PubMed ID: 11981057
[TBL] [Abstract][Full Text] [Related]
34. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
[TBL] [Abstract][Full Text] [Related]
35. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
37. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
38. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
40. Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs.
Pradelli E; Karimdjee-Soilihi B; Michiels JF; Ricci JE; Millet MA; Vandenbos F; Sullivan TJ; Collins TL; Johnson MG; Medina JC; Kleinerman ES; Schmid-Alliana A; Schmid-Antomarchi H
Int J Cancer; 2009 Dec; 125(11):2586-94. PubMed ID: 19544560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
